Scarica l'app Stockscreener
18.50
0.71%
0.13
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Adaptive Biotechnologies Reports Strong Revenue Growth Amid Strategic Shift - AD HOC NEWS
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - The Manila Times
Biotech using immune genetics schedules Feb. and March investor webcasts - Stock Titan
The Analyst Verdict: Adaptive Biotechnologies In The Eyes Of 4 Experts - Benzinga
Guggenheim Raises Price Target for ADPT to $21, Maintains Buy Ra - GuruFocus
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 - The Manila Times
First Week of March 20th Options Trading For Adaptive Biotechnologies (ADPT) - Nasdaq
Sumitomo Mitsui Trust Group Inc. Trims Holdings in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Aug Selloffs: Will Adaptive Biotechnologies Corporation stock go up in YEARJuly 2025 Spike Watch & Comprehensive Market Scan Insights - baoquankhu1.vn
Adaptive Biotechnologies Insider Sold Shares Worth $1,411,131, According to a Recent SEC Filing - marketscreener.com
Adaptive Biotechnologies’ Lo Francis sells $1.4m in shares By Investing.com - Investing.com South Africa
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells 79,590 Shares of Stock - MarketBeat
Adaptive Biotechnologies’ Lo Francis sells $1.4m in shares - Investing.com
Adaptive Biotechnologies CFO Piskel sells $77,220 in shares - Investing.com
Adaptive Biotechnologies Exec Sells Shares - TradingView — Track All Markets
Assessing Adaptive Biotechnologies (ADPT) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
Piper Sandler reiterates Overweight rating on Adeptus Biotechnologies stock By Investing.com - Investing.com Australia
What's Going On With Adaptive Biotechnologies Shares Tuesday? - Benzinga
Piper Sandler reiterates Overweight rating on Adeptus Biotechnologies stock - Investing.com
Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Revenue Growth Surges Over 100%, Analysts Eye 9.53% Upside - DirectorsTalk Interviews
Adaptive Biotechnologies Touts clonoSEQ MRD Growth, Targets Companywide Profitability in 2026 - Yahoo Finance
Adaptive Biotechnologies (ADPT) Surpasses Q4 Revenue Estimates, Shares Climb - GuruFocus
Adaptive Biotechnologies' Q4 Preliminary Revenue Rises 51%; Shares Jump in Premarket Trading - marketscreener.com
Adaptive Biotechnologies Rises 10% As Revenue Surges Over 50% - Nasdaq
Adaptive Biotechnologies reports 55% revenue growth in 2025 - Investing.com
Adaptive Biotechnologies reports 55% revenue growth in 2025 By Investing.com - Investing.com UK
Adaptive Biotechnologies announces preliminary fourth quarter and full year 2025 results - marketscreener.com
Adaptive Biotechnologies Reports Preliminary Financial Results for Q4 and Full Year 2025, Highlighting Significant Revenue Growth - Quiver Quantitative
Adaptive Biotechnologies stock soars after strong Q4 revenue beat - Investing.com
Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results - The Manila Times
Adaptive Biotechnologies stock soars after strong Q4 revenue beat By Investing.com - Investing.com Canada
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells $164,400.00 in Stock - Defense World
Adaptive Biotechnologies Corporation $ADPT Holdings Trimmed by Peregrine Capital Management LLC - MarketBeat
Adaptive Biotechnologies CSO Robins sells $164k in shares By Investing.com - Investing.com UK
Insider Sell: Harlan Robins Sells Shares of Adaptive Biotechnolo - GuruFocus
Adaptive Biotechnologies CSO Robins sells $164k in shares - Investing.com India
Meme Stocks: Will Adaptive Biotechnologies Corporation (1HM) stock profit from automation waveMarket Movers & Smart Money Movement Alerts - Улправда
Adaptive Biotechnologies assumed with an Equal Weight at Morgan Stanley - MSN
Adaptive Biotechnologies Insider Sold Shares Worth $1,948,719, According to a Recent SEC Filing - marketscreener.com
Adaptive Biotechnologies’ Lo Francis sells $76,895 in shares By Investing.com - Investing.com UK
Chad Robins Sells 124,998 Shares of Adaptive Biotechnologies Cor - GuruFocus
Adaptive Biotechnologies CEO Robins sells $1.95 million in shares - Investing.com
Adaptive Biotechnologies CEO Sells Over $1.9 Million in Company Stock - TradingView — Track All Markets
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Up 6.7%Time to Buy? - MarketBeat
Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale - TechStock²
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Francis Lo Sells 3,125 Shares - MarketBeat
Adaptive Biotechnologies CPO Lo sells $50k in ADPT stock By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CPO Lo sells $50k in ADPT stock - Investing.com India
Adaptive Biotechnologies Corporation (ADPT) Stock Analysis: Unraveling Its 22.8% Potential Upside - DirectorsTalk Interviews
Adaptive Biotechnologies discloses it's raising $15 million for subsidiary - The Business Journals
Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
1.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):